Researchers have identified two new genetic mutations that cause a significant number of the hardest-to-treat kinds of ovarian cancer, and say they point to a new "on-off" switch for tumors.
Medicare patients with more doctors to choose from do not necessarily get more or better care, researchers reported on Thursday in an analysis demonstrating how complicated U.S. healthcare reform will be.
Thousands of AIDS patients in India are not receiving treatment on time, underscoring huge challenges the country faces as it combats the disease, the Global Fund To Fight AIDS, Tuberculosis and Malaria said on Thursday.
With the advent of folic-acid supplementation of certain foods, few Canadians are now getting too little of the B vitamin, a new study estimates -- in findings that question the need for children and men to get additional folic acid from vitamins.
The nation's health care tab will go up — not down — as a result of President Barack Obama's sweeping overhaul. That's the conclusion of a government forecast Thursday, which also predicts the increase will be modest.
World powers have reached an accord, after weeks of tough talks, on a document to be adopted at a Millennium Development summit this month for which Secretary General Ban Ki-moon is seeking billions of dollars of new funding.
Health giant Johnson & Johnson is donating about $200 million in cash and medicine to a sweeping United Nations program created to improve the health and lives of people in poor countries.
THURSDAY, Sept. 9 (HealthDay News) -- A newly developed
assessment tool may give doctors and parents a heads-up about the kinds of
medical problems that may face premature infants, researchers say.
New U.S. reforms are poised to dramatically shift the nation's healthcare spending, not only curbing Medicare costs but also pumping more money toward the private sector as roughly 32 million people gain coverage.
Daily tablets of large doses of B vitamins can halve the rate of brain shrinkage in elderly people with memory problems and may slow their progression toward dementia, data from a British trial showed on Wednesday,